These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 8396090)
1. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. Fitzgeorge RB; Lever S; Baskerville A J Antimicrob Chemother; 1993 Jun; 31 Suppl E():171-6. PubMed ID: 8396090 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. Fitzgeorge RB; Featherstone AS; Baskerville A J Antimicrob Chemother; 1990 Jan; 25 Suppl A():101-8. PubMed ID: 2154427 [TBL] [Abstract][Full Text] [Related]
3. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH; Shinzato T; Edelstein MA J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [TBL] [Abstract][Full Text] [Related]
5. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease. Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of macrolides against intracellular Legionella pneumophila. Segreti J; Meyer P; Kapell K Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Shinzato T; Doyle E; Edelstein MA Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [TBL] [Abstract][Full Text] [Related]
10. Studies on ciprofloxacin therapy of experimental Legionnaires' disease. Fitzgeorge RB; Gibson DH; Jepras R; Baskerville A J Infect; 1985 May; 10(3):194-203. PubMed ID: 3161954 [TBL] [Abstract][Full Text] [Related]
11. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530 [TBL] [Abstract][Full Text] [Related]
12. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Weiss WJ; Edelstein MA Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655 [TBL] [Abstract][Full Text] [Related]
13. [Treatment for Legionnaires' disease. Macrolides or quinolones?]. Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936 [TBL] [Abstract][Full Text] [Related]
14. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs. García-de-Lomas J; Millás E; Lázaro MA; Bermejo M; Gimeno C; Navarro D; Sánchez S Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):420-3. PubMed ID: 9758285 [TBL] [Abstract][Full Text] [Related]
15. Experimental transmission of legionnaires' disease by exposure to aerosols of Legionella pneumophila. Baskerville A; Fitzgeorge RB; Broster M; Hambleton P; Dennis PJ Lancet; 1981 Dec 19-26; 2(8260-61):1389-90. PubMed ID: 6118761 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of SCH27899 in an animal model of Legionnaires' disease using immunocompromised A/J mice. Brieland JK; Loebenberg D; Menzel F; Hare RS Antimicrob Agents Chemother; 2000 May; 44(5):1333-6. PubMed ID: 10770771 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. Stamler DA; Edelstein MA; Edelstein PH Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446 [TBL] [Abstract][Full Text] [Related]
18. Is a 5 day course of azithromycin enough for infections caused by Legionella pneumophila? Matute AJ; Schurink CA; Hoepelman IM J Antimicrob Chemother; 2000 Jun; 45(6):930-1. PubMed ID: 10837459 [No Abstract] [Full Text] [Related]
19. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Griffin AT; Peyrani P; Wiemken T; Arnold F Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309 [TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin. Fitzgeorge RB; Baskerville A; Featherstone AS Lancet; 1986 Mar; 1(8479):502-3. PubMed ID: 2869238 [No Abstract] [Full Text] [Related] [Next] [New Search]